120 related articles for article (PubMed ID: 890676)
21. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A
Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881
[TBL] [Abstract][Full Text] [Related]
22. The hypronosticon test in breast cancer.
Roberts JG; Williams M; Henk JM; Bligh AS; Baum M
Clin Oncol; 1975 Mar; 1(1):33-43. PubMed ID: 1204270
[No Abstract] [Full Text] [Related]
23. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
Anticancer Res; 1998; 18(2B):1243-9. PubMed ID: 9615795
[TBL] [Abstract][Full Text] [Related]
24. Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients.
Frenay M; Namer M; Boublil JL; Khater R; Viot M; François E; Milano G
Bull Cancer; 1988; 75(6):533-9. PubMed ID: 3416085
[TBL] [Abstract][Full Text] [Related]
25. Urinary hydroxyproline and prognosis in human breast cancer.
Grant CS; Hoare SA; Millis RR; Hayward JL; Wang DY
Br J Surg; 1984 Feb; 71(2):105-8. PubMed ID: 6692099
[TBL] [Abstract][Full Text] [Related]
26. Biochemical markers in breast carcinoma.
Duffy MJ; Hynes N; Groarke Y; Oliver J; O'Broin A; Duffy G
Ir Med J; 1978 Sep; 71(12):408-13. PubMed ID: 700980
[No Abstract] [Full Text] [Related]
27. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
Gasser AB; Depierre D; Alberto P; Courvoisier B
Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
[TBL] [Abstract][Full Text] [Related]
28. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
Radom S; Zulawski M; Golebiowska D
Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776
[No Abstract] [Full Text] [Related]
29. The effects of calcitonin on the metabolic disturbances surrounding widespread bony metastases.
Parsons V; Dalley V; Brinkley D; Davies C; Vernon A
Acta Endocrinol (Copenh); 1974 Jun; 76(2):286-301. PubMed ID: 4406591
[No Abstract] [Full Text] [Related]
30. Nuclear medicine procedures in obstetrics and gynecology.
Gorten RJ
Radiol Clin North Am; 1974 Apr; 12(1):147-65. PubMed ID: 4820825
[No Abstract] [Full Text] [Related]
31. Detection of hepatic metastases from cancer of the breast.
Sugarbaker PH; Beard JO; Drum DE
Am J Surg; 1977 Apr; 133(4):531-5. PubMed ID: 848688
[TBL] [Abstract][Full Text] [Related]
32. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
[TBL] [Abstract][Full Text] [Related]
33. Free serum hydroxyproline and total urinary hydroxyproline for the detection of skeletal metastasis.
Gasser AB; Depierre D; Mermillod B; Courvoisier B
Br J Cancer; 1982 Mar; 45(3):477-81. PubMed ID: 7041941
[No Abstract] [Full Text] [Related]
34. Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase.
Tartter PI; Slater G; Gelernt I; Aufses AH
Ann Surg; 1981 Mar; 193(3):357-60. PubMed ID: 7212797
[TBL] [Abstract][Full Text] [Related]
35. Plasma sialyltransferase in patients with breast cancer.
Lee YT; Tokes ZA; Csipke CP
J Surg Oncol; 1980; 14(2):159-65. PubMed ID: 7392638
[TBL] [Abstract][Full Text] [Related]
36. Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma.
Ditzel J; Jordal R; Riskaer N
Acta Endocrinol (Copenh); 1968 Nov; 59(3):353-61. PubMed ID: 5754976
[No Abstract] [Full Text] [Related]
37. [Tumor markers in bronchial cancer: do they have a role in daily practice?].
Feintrenie X; Briancon S; Pichene M; Lamy P
Rev Pneumol Clin; 1984; 40(6):345-54. PubMed ID: 6085181
[TBL] [Abstract][Full Text] [Related]
38. Biological markers in gynecologic cancers. An overview.
Dini MM; Miller M
IMJ Ill Med J; 1984 Sep; 166(3):166-71. PubMed ID: 6208177
[No Abstract] [Full Text] [Related]
39. Assessment of biochemical tests to screen for metastases in patients with breast cancer.
Coombes RC; Powles TJ; Gazet JC; Nash AG; Ford HT; McKinna A; Neville AM
Lancet; 1980 Feb; 1(8163):296-7. PubMed ID: 6101748
[TBL] [Abstract][Full Text] [Related]
40. The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer.
Cooper EH; Turner R; Steele L; Neville AM; Mackay AM
Br J Cancer; 1975 Jan; 31(1):111-7. PubMed ID: 239735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
